In the BioHarmony Drug Report Database
Asfotase alfa
Strensiq (asfotase alfa) is an enzyme pharmaceutical. Asfotase alfa was first approved as Strensiq on 2015-08-28. It is used to treat hypophosphatasia in the USA. It has been approved in Europe to treat hypophosphatasia.
Trade Name
|
Strensiq |
|---|---|
Common Name
|
asfotase alfa |
ChEMBL ID
|
CHEMBL2108311 |
Indication
|
hypophosphatasia |
Drug Class
|
Enzymes |
Image (chem structure or protein)
